NASDAQ:VLON

Vallon Pharmaceuticals Stock Forecast, Price & News

$4.44
-0.22 (-4.72 %)
(As of 04/12/2021 12:00 AM ET)
Add
Compare
Today's Range
$4.40
Now: $4.44
$4.58
50-Day Range
$4.32
MA: $5.26
$7.04
52-Week Range
$4.30
Now: $4.44
$9.90
Volume337,774 shs
Average Volume76,295 shs
Market Capitalization$30.24 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Vallon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of prescription drugs for central nervous system disorders. The company develops abuse-deterrent amphetamine immediate-release, an abuse-deterrent oral formulation of immediate-release dextroamphetamine for the treatment of attention-deficit/hyperactivity disorder and narcolepsy. It also develops ADMIR, an abuse deterrent formulation of Ritalin. The company was incorporated in 2018 and is based in Philadelphia, Pennsylvania.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:VLON
CUSIPN/A
CIKN/A
Phone267 207 3606
Employees2
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$30.24 million
Next Earnings Date7/5/2021 (Estimated)
OptionableNot Optionable

MarketRank

Overall MarketRank

0.33 out of 5 stars

Medical Sector

1781st out of 2,016 stocks

Biotechnology Industry

113th out of 144 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
$4.44
-0.22 (-4.72 %)
(As of 04/12/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive VLON News and Ratings via Email

Sign-up to receive the latest news and ratings for VLON and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Vallon Pharmaceuticals (NASDAQ:VLON) Frequently Asked Questions

What stocks does MarketBeat like better than Vallon Pharmaceuticals?

Wall Street analysts have given Vallon Pharmaceuticals a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Vallon Pharmaceuticals wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Vallon Pharmaceuticals' next earnings date?

Vallon Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Monday, July 5th 2021.
View our earnings forecast for Vallon Pharmaceuticals
.

Who are Vallon Pharmaceuticals' key executives?

Vallon Pharmaceuticals' management team includes the following people:
  • Mr. David C. Baker, CEO, Pres & Director (Age 58, Pay $339.9k)
  • Ms. Penny S. Toren, Sr. VP of Regulatory Affairs & Program Management (Age 54, Pay $242.05k)
  • Dr. Timothy M. Whitaker, Chief Medical Officer (Age 62)

Who are some of Vallon Pharmaceuticals' key competitors?

When did Vallon Pharmaceuticals IPO?

(VLON) raised $15 million in an initial public offering on Wednesday, February 10th 2021. The company issued 1,700,000 shares at a price of $8.00-$10.00 per share. ThinkEquity (a division of Fordham Financial Management) acted as the underwriter for the IPO.

What is Vallon Pharmaceuticals' stock symbol?

Vallon Pharmaceuticals trades on the NASDAQ under the ticker symbol "VLON."

When does the company's lock-up period expire?

Vallon Pharmaceuticals' lock-up period expires on Monday, August 9th. Vallon Pharmaceuticals had issued 2,250,000 shares in its IPO on February 10th. The total size of the offering was $18,000,000 based on an initial share price of $8.00. After the end of the company's lock-up period, company insiders and major shareholders will be able to sell their shares of the company.

How do I buy shares of Vallon Pharmaceuticals?

Shares of VLON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Vallon Pharmaceuticals' stock price today?

One share of VLON stock can currently be purchased for approximately $4.44.

How much money does Vallon Pharmaceuticals make?

Vallon Pharmaceuticals has a market capitalization of $30.24 million.

How many employees does Vallon Pharmaceuticals have?

Vallon Pharmaceuticals employs 2 workers across the globe.

What is Vallon Pharmaceuticals' official website?

The official website for Vallon Pharmaceuticals is www.vallon-pharma.com.

How can I contact Vallon Pharmaceuticals?

The company can be reached via phone at 267 207 3606.


This page was last updated on 4/13/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.